ΠΠΎΡΠ΅ΡΠ½Π°HLBBF β’ OTCMKTS
add
H. Lundbeck A/S Class B
ΠΠΊΡΠΈΡΠ°ΠΠΈΠ΄Π΅Ρ Ρ Π·Π°ΡΡΠΈΡΠΈ ΠΆΠΈΠ²ΠΎΡΠ½Π΅ ΡΡΠ΅Π΄ΠΈΠ½Π΅ΠΠΊΡΠΈΡΠ° ΠΊΠΎΡΠΎΠΌ ΡΠ΅ ΡΡΠ³ΡΡΠ΅ Π½Π° Π±Π΅ΡΠ·ΠΈ Ρ ΡΠ΅Π³ΠΈΠΎΠ½Ρ Π‘ΠΠ
ΠΡΠ΅ΡΡ
ΠΎΠ΄Π½ΠΎ Π·Π°ΠΊΡΡΡΠ΅Π½ΠΎ
5,60Β $
ΠΠΎΠ΄ΠΈΡΡΠΈ ΠΎΠΏΡΠ΅Π³
4,63Β $ - 7,50Β $
Π’ΡΠΆΠΈΡΠ½Π° Π²ΡΠ΅Π΄Π½ΠΎΡΡ
41,10Β ΠΌΠ»ΡΠ΄. DKK
ΠΡΠΎΡΠ΅ΡΠ½Π° ΠΊΠΎΠ»ΠΈΡΠΈΠ½Π°
68,00
Π¦Π΅Π½Π°/Π·Π°Ρ.
-
ΠΠΎΠ±ΠΈΡ ΠΎΠ΄ Π΄ΠΈΠ²ΠΈΠ΄Π΅Π½Π΄ΠΈ
-
ΠΠ΅ΡΡΠΈ ΡΠ° ΡΡΠΆΠΈΡΡΠ°
Π€ΠΈΠ½Π°Π½ΡΠΈΡΠ΅
ΠΠΈΠ»Π°Π½Ρ ΡΡΠΏΠ΅Ρ
Π°
ΠΡΠΈΡ
ΠΎΠ΄
ΠΠ΅ΡΠΎ ΠΏΡΠΈΡ
ΠΎΠ΄
(DKK) | ΡΠ΅ΠΏ 2024.info | ΠΡΠΎΠΌΠ΅Π½Π° Π/Π |
---|---|---|
ΠΡΠΈΡ
ΠΎΠ΄ | 5,72Β ΠΌΠ»ΡΠ΄. | 15,55% |
Π’ΡΠΎΡΠΊΠΎΠ²ΠΈ ΠΏΠΎΡΠ»ΠΎΠ²Π°ΡΠ° | 3,67Β ΠΌΠ»ΡΠ΄. | 23,76% |
ΠΠ΅ΡΠΎ ΠΏΡΠΈΡ
ΠΎΠ΄ | 777,00Β ΠΌΠΈΠ». | 14,94% |
ΠΠ΅ΡΠΎ ΠΏΡΠΎΡΠΈΡΠ°Π±ΠΈΠ»Π½ΠΎΡΡ | 13,58 | -0,51% |
ΠΠ°ΡΠ°Π΄Π° ΠΏΠΎ Π°ΠΊΡΠΈΡΠΈ | 1,30 | 11,11% |
EBITDA | 1,43Β ΠΌΠ»ΡΠ΄. | 3,10% |
ΠΡΠ΅ΠΊΡΠΈΠ²Π½Π° ΠΏΠΎΡΠ΅ΡΠΊΠ° ΡΡΠΎΠΏΠ° | -6,15% | β |
ΠΠΈΠ»Π°Π½Ρ ΡΡΠ°ΡΠ°
Π£ΠΊΡΠΏΠ½Π° Π°ΠΊΡΠΈΠ²Π°
Π£ΠΊΡΠΏΠ½Π΅ ΠΎΠ±Π°Π²Π΅Π·Π΅
(DKK) | ΡΠ΅ΠΏ 2024.info | ΠΡΠΎΠΌΠ΅Π½Π° Π/Π |
---|---|---|
ΠΠΎΡΠΎΠ²ΠΈΠ½Π° ΠΈ ΠΊΡΠ°ΡΠΊ. ΡΠ»Π°Π³Π°ΡΠ° | 8,32Β ΠΌΠ»ΡΠ΄. | 95,90% |
Π£ΠΊΡΠΏΠ½Π° Π°ΠΊΡΠΈΠ²Π° | 39,52Β ΠΌΠ»ΡΠ΄. | 4,89% |
Π£ΠΊΡΠΏΠ½Π΅ ΠΎΠ±Π°Π²Π΅Π·Π΅ | 15,68Β ΠΌΠ»ΡΠ΄. | 2,04% |
Π£ΠΊΡΠΏΠ½Π° Π²ΡΠ΅Π΄Π½ΠΎΡΡ Π°ΠΊΡΠΈΡΠ° | 23,84Β ΠΌΠ»ΡΠ΄. | β |
ΠΠ΅ΠΈΡΠΏΠ»Π°ΡΠ΅Π½Π΅ Π°ΠΊΡΠΈΡΠ΅ | 996,15Β ΠΌΠΈΠ». | β |
Π’ΡΠΆΠΈΡΠ½Π° ΠΏΡΠ΅ΠΌΠ° Π½ΠΎΠΌΠΈΠ½Π°Π»Π½ΠΎΡ | 0,23 | β |
ΠΠΎΠ²ΡΠ°ΡΠ°Ρ Π°ΠΊΡΠΈΠ²Π΅ | 6,11% | β |
ΠΠΎΠ²ΡΠ°ΡΠ°Ρ ΠΊΠ°ΠΏΠΈΡΠ°Π»Π° | 8,67% | β |
Π’ΠΎΠΊ Π½ΠΎΠ²ΡΠ°
ΠΠ΅ΡΠΎ ΠΏΡΠΎΠΌΠ΅Π½Π° Ρ Π½ΠΎΠ²ΡΡ
(DKK) | ΡΠ΅ΠΏ 2024.info | ΠΡΠΎΠΌΠ΅Π½Π° Π/Π |
---|---|---|
ΠΠ΅ΡΠΎ ΠΏΡΠΈΡ
ΠΎΠ΄ | 777,00Β ΠΌΠΈΠ». | 14,94% |
ΠΠΎΡΠΎΠ²ΠΈΠ½Π° ΠΈΠ· ΠΏΠΎΡΠ»ΠΎΠ²Π°ΡΠ° | 2,30Β ΠΌΠ»ΡΠ΄. | 54,50% |
ΠΠΎΡΠΎΠ²ΠΈΠ½Π° ΠΈΠ· ΠΈΠ½Π²Π΅ΡΡΠΈΡΠ°ΡΠ° | -101,00Β ΠΌΠΈΠ». | -4,12% |
ΠΠΎΡΠΎΠ²ΠΈΠ½Π° ΠΈΠ· ΡΠΈΠ½Π°Π½ΡΠΈΡΠ°ΡΠ° | -24,00Β ΠΌΠΈΠ». | 97,05% |
ΠΠ΅ΡΠΎ ΠΏΡΠΎΠΌΠ΅Π½Π° Ρ Π½ΠΎΠ²ΡΡ | 2,17Β ΠΌΠ»ΡΠ΄. | 270,77% |
Π‘Π»ΠΎΠ±ΠΎΠ΄Π°Π½ ΡΠΎΠΊ Π½ΠΎΠ²ΡΠ° | 985,25Β ΠΌΠΈΠ». | -28,86% |
ΠΡΠ½ΠΎΠ²Π½ΠΈ ΠΏΠΎΠ΄Π°ΡΠΈ
H. Lundbeck A/S, commonly referred to as Lundbeck, is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The companyβs products are targeted at brain diseases, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease and migraine.
Headquartered in Copenhagen, Denmark, Lundbeck has approximately 5,600 employees in more than 50 countries, and their products are registered in more than 100 countries. They have production facilities in Denmark, France and Italy and their research centers are based in Denmark and the US.
Lundbeck is listed on the Copenhagen Stock Exchange.
Lundbeck is a full member of the European Federation of Pharmaceutical Industries and Associations and of the International Federation of Pharmaceutical Manufacturers and Associations Wikipedia
ΠΠ·Π²ΡΡΠ½ΠΈ Π΄ΠΈΡΠ΅ΠΊΡΠΎΡ: CEO
ΠΠ°ΡΡΠΌ ΠΎΡΠ½ΠΈΠ²Π°ΡΠ°
14. 8. 1915.
ΠΠ΅Π±-ΡΠ°ΡΡ
ΠΡΠΎΡ Π·Π°ΠΏΠΎΡΠ»Π΅Π½ΠΈΡ
5.500